Facts & Figures

Founded: 1978

Founder: William A. Linton, Chairman and CEO

Ownership: Employees and investors; privately held

Number of Employees: 920

Number of Products: 2,000+

Patent Leadership: Promega holds ~200 patents focused in the areas of:

  • Nucleic acid purification
  • Human identification
  • Bioluminescence
  • Coupled in vitro transcription and translation
  • Cell biology
Licensing: Promega offers licensing opportunities for a number of key technologies. Currently the following technologies are available for licensing:
  • Vector Label License - Green Fluorescent Protein
  • Vector Label License - Luciferase
  • Apoptosis Marker Antibodies
  • Short Tandem Repeats (STRs)
Annual Revenue: Over $220 million

Percent of Revenues Invested in R&D: 11%